πŸ‡ΊπŸ‡Έ FDA
Patent

US 11180468

Prodrugs of urolithins and uses thereof

granted A61KA61K31/366A61K31/4025

Quick answer

US patent 11180468 (Prodrugs of urolithins and uses thereof) held by Amazentis SA expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Amazentis SA
Grant date
Tue Nov 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/366, A61K31/4025, A61K45/06, A61P